Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 7Terminated 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Head and Neck Neoplasms 4Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Radiation Injuries 2Ovarian Neoplasms 2Drug-Related Side Effects and Adverse Reactions 2Brain Neoplasms 2Xerostomia 1Wilms Tumor 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Teratoma 1Sarcoma, Ewing 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Ovarian Germ Cell Cancer 1Oropharyngeal Neoplasms 1Neurotoxicity Syndromes 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Plasma Cell 1Nasopharyngeal Neoplasms 1Multiple Myeloma 1Mucositis 1Mouth Neoplasms 1Medulloblastoma 1Liver Neoplasms 1Laryngeal Neoplasms 1Kidney Neoplasms 1

Interventions

Paclitaxel 18Carboplatin 14Topotecan 8liposomal doxorubicin 6Cyclophosphamide 5Cisplatin 5Gemcitabine 4Docetaxel 4oregovomab 3Immunoenzyme Techniques 3Etoposide 3Capecitabine 3pembrolizumab 2fludarabine phosphate 2aldesleukin 2Taxes 2Surgical Procedures, Operative 2Stem Cell Transplantation 2STA 9090 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Nivolumab 2Microarray Analysis 2Magnetic Resonance Spectroscopy 2Lenalidomide 2Fulvestrant 2Fluorodeoxyglucose F18 2Flow Cytometry 2Filgrastim 2Cytoreduction Surgical Procedures 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Carcinoma, Ovarian Epithelial × Amifostine × Clear all
NCT00003624 2013-04-11

Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer

GOG Foundation

Phase 2 Terminated
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡